Monitor the upcoming Q1 2026 earnings report to confirm if the strong preliminary revenue growth and improved cash position translate into sustained profitability, as the 2025 results showed declining revenue and a significant EPS miss.
Price Chart
Executive Summary
BIO-key reported 2025 full-year results with $6.1M revenue (down 12% YoY) and a net loss of $4.6M ($0.69/share), missing consensus EPS of -$0.06. However, the company highlighted a strong start to 2026 with preliminary Q1 revenue of $2.2M, up 37% YoY, and secured new defense and financial sector contracts. Cash position improved to $2.7M.
Key Financial Metrics
Key Facts
- 2025 revenue was $6.1M, down 12% from $6.9M in 2024
- 2025 net loss was $4.6M, or ($0.69) per share, compared to a net loss of $4.3M, or ($2.09) per share, in 2024
- Preliminary Q1 2026 revenue is $2.2M, up 37% year-over-year
- Cash position increased to $2.7M at the end of 2025, up from $0.4M in 2024
- Secured $500k in new defense orders and a $1.04M license renewal with a foreign bank in Q1 2026
Financial Impact
2025 revenue down 12% YoY to $6.1M, net loss of $4.6M ($0.69/share). Preliminary Q1 2026 revenue of $2.2M up 37% YoY.
Risk Factors
- 2025 revenue declined 12% YoY due to the transition from Swivel Secure products and a large contract renewal in 2024
- The company reported a net loss of $4.6M in 2025 and has a history of losses, raising concerns about its ability to achieve break-even in 2026
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-010506 |
| Document: bkyi20260331_8k.htm | 0001437749-26-010506 |
| Document: 0001437749-26-010506-index-headers.html | 0001437749-26-010506 |
| Document: 0001437749-26-010506-index.html | 0001437749-26-010506 |
| Document: 0001437749-26-010506.txt | 0001437749-26-010506 |
| 8-K Data (Synthetic) | 0001437749-26-010506 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | S-1 | $1.65 | awaiting T+60 | — | $2.73 (−65.76%) |
Oct 6, 2026 21d ago | DEFA14A | $1.76 | awaiting T+60 | — | $2.73 (+55.40%) |
Oct 6, 2026 21d ago | 8-K | $1.76 | awaiting T+60 | — | $2.73 (+55.40%) |
Oct 2, 2026 25d ago | 8-K | $1.93 | awaiting T+60 | — | $2.73 (−41.71%) |
Sep 29, 2026 28d ago | Press Release | $3.12 | awaiting T+60 | — | $2.73 (−12.34%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | — | $2.73 (+7.91%) |
Aug 14, 2026 10w ago | 8-K | $3.18 | awaiting T+60 | — | $2.73 (+13.99%) |
Aug 13, 2026 10w ago | Press Release | $3.18 | awaiting T+60 | — | $2.73 (−13.99%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | — | $2.73 (−34.41%) |
Jul 28, 2026 13w ago | Press Release | $4.25 $2.10 | ▼ −50.59% | ▼ −54.94% | $2.73 (−35.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers